First Light Asset Management »

Recro Pharma shares owned by First Light Asset Management

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 20M 0.35
2023-09-30 $9.2M 20M 0.47
2023-06-30 $15M 13M 1.10
2023-03-31 $11M 8.9M 1.19
2022-12-31 $13M 8.6M 1.49

More positions owned by First Light Asset Management

Karuna Therapeutics Common Stocks
Alphatec Holdings Common Stocks (ATEC)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Pliant Therapeutics Common Stocks (PLRX)
Neogenomics Common Stocks (NEO)
Transmedics Group Common Stocks (TMDX)
Si-bone Common Stocks (SIBN)
Atricure Common Stocks (ATRC)
Paragon 28 Common Stocks (FNA)
Model N Common Stocks (MODN)
Tactile Systems Technology Common Stocks (TCMD)
Prothena Corporation Common Stocks (PRTA)
Ultragenyx Pharmaceutical Common Stocks (RARE)
Performant Financial Corporation Common Stocks (PFMT)

View all positions for First Light Asset Management

Top funds holding Recro Pharma

First Light Asset Management
AWM Investment Company
Royce & Associates
Samjo Management
Vanguard Group
OV Management
Caligan Partners
First Eagle Investment Management
Alyeska Investment Group
Nantahala Capital Management
Clear Harbor Asset Management
Titleist Asset Management
Citadel Advisors
Millennium Management
Global Retirement Partners

View all funds holding Recro Pharma